OSF
open access
Maximizing Systemic Anti-Tumor Immune Responses in Pancreatic Cancer Using Histotripsy in Combination with Immuno-Therapeutic Approaches
New therapeutic strategies and paradigms for pancreatic cancer are direly needed. Recently, our research team completed proof-of-concept studies demonstrating that histotripsy is effective at targeting the pancreas. Work by our team and others has shown that histotripsy is also effective in inducing
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Ipilimumab +/- Vaccine Therapy in Treating Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer#383563
- Neoantigen Vaccines in Pancreatic Cancer in the Window Prior to Surgery#311194
- Vaccine Therapy Plus QS21 in Treating Patients With Advanced Pancreatic or Colorectal Cancer#256972
- Targeted therapy in pancreatic ductal adenocarcinoma: current advances and challenges#667087
- QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy#195318
Record · ID 976971
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive